VETIGEL® is a flowable hemostatic hydrogel designed specifically for animal health. VETIGEL® is​ comprised of algae-and fungi-derived biopolymers. Its components are sodium alginate, poly (N-acetyl-​D-glucosamine, D-glucosamine), and water.  

VETIGEL® stops bleeding in seconds by ionically cross-linking and forming a non-porous mechanical barrier. The body’s natural clot does not incorporate into the gel.

VETIGEL® is applied by following four steps:  

1. 1. Prime the syringe  
   2. Use gauze to remove excess blood from the field  
   3. Perpendicularly administer gel, directly to the wound  
   4. Shear the gel against the tissue while pulling the syringe away from the wound  

VETIGEL® can be used on a variety of procedures, including but not limited to: Dental extractions, oral mass removals, abdominal and thoracic mass removals, soft organ biopsies, enucleations, spays and neuters, amputations, venous and arterial bleeds, epistaxis, cholecystectomies, catheterization, lacerations, laminectomies/hemi-laminectomies, and ear and tail docking.

VETIGEL® is absorbable and intended to absorb within weeks of application, while minor residuals may take longer to absorb. If removed​, VETIGEL® does not disrupt the fibrin patch, unlike other hemostatic products where surface clots may get​ incorporated and lead to a bleeding reoccurrence when removed.  

VETIGEL® should be stored dry and maintained between 2-25˚C upon receipt. VETIGEL® should not be​ stored in direct sunlight. It has a shelf-life of 24 months from date of manufacture.

Yes, VETIGEL® can be applied topically.

VETIGEL® is applied by following four steps:​

VETIGEL® is a sterile medical device that undergoes terminal sterilization through gamma irradiation.

VETIGEL® has been used in craniotomies, laminectomies, and other cerebrospinal procedures. It is recommended to fully remove all material post-treatment. Best practices are to remove all foreign material, including VETIGEL®, in
cerebrospinal procedures.

VETIGEL® Precision Accessories are sterilized via gamma irradiation.

VETIGEL®’s mechanism of action is mechanical and occurs independently of the patient’s clotting​ process. VETIGEL® creates a strong, adhesive mechanical barrier at the wound site that will maintain​ hemostatic effect while it remains in contact with the wound. VETIGEL® is recommended to be left in​ place in patients with coagulopathy as there may not be a strong endogenous clot.​

VETIGEL® was assessed for its biocompatibility per ISO 10993 (human medical device biocompatibility​ standards) that was interpreted for veterinary use. This testing included cytotoxicity, intracutaneous​ reactivity, maximization sensitization, pyrogenicity, genotoxicity, and more. The results of the testing​ confirmed that VETIGEL® is biocompatible and give assurance that VETIGEL® does not pose risk of​ rejection by the body.

VETIGEL® is comprised of sodium alginate dissolved in water with solid particles of poly (N-acetyl-D-​glucosamine, D-glucosamine) dispersed in it. In two limited studies, use of VETIGEL® was not shown to​ result in a clinically significant increase in adhesion formation as compared to existing standards of care.​

CONTRAINDICATIONS​

WARNINGS​